Update Re Senate Hearing for R&D Tax Incentive Bill, June 2020
9 July 2020 The Senate Economics Legislation Committee met on Monday 29 June 2020 to review the “Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019” (RDTI Bill). The reporting date for the inquiry is expected to…
Victoria’s health industry welcomes Andrews government
30 November 2018 On behalf of its members, BioMelbourne Network congratulates the Hon Daniel Andrews MP and the Victorian Labor party on their re-election at the 2018 state election. BioMelbourne Network CEO Dr Krystal Evans welcomes the opportunity…
2018 state election priorities
Health industry priorities for Victoria Victoria is the state that will change the future of health. The health industry is the industrial sector that encompasses biotechnology, medical technology, pharmaceuticals and digital healthcare that enables research and development as…
BioMelbourne Network opposes cuts to the R&D Tax Incentive
5 November 2018 BioMelbourne Network has made a submission to the Senate Inquiry regarding the changes to the R&D Tax Incentive as outlined in the Treasury Laws Amendment. BioMelbourne Network is opposed to the proposed changes to the…
Media release: Calls to back the health industry for Victoria’s future
BioMelbourne Network is challenging state election candidates to adopt initiatives that make the health industry a top economic priority for Victoria.
Joint statement: The health industry as an economic priority for Victoria
Victoria has world-leading competitive advantages in the health industry, which encompasses health and medical research, biotechnology, medical technology, pharmaceuticals, digital health, healthcare delivery, global health and health services. Victoria’s healthcare sector contributes to more than $30 billion to…
BioMelbourne Network submission regarding R&D Tax Incentive
On behalf of the members, BioMelbourne Network has made a submission to Treasury regarding the proposed changes to the R&D Tax Incentive. In terms of our overall consideration of the proposed changes to the R&D Tax Incentive, it…
BioMelbourne Network Policy Principles – 2018 State Election
The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now employing 75,000…
Media Release – Industry calls for Medical Technologies and Pharmaceuticals Innovation Hub
Media Release – Monday 20th November 2017 At its Annual General Meeting today, BioMelbourne Network will launch a pre-budget submission calling for the Victorian Government to invest in a Medical Technologies and Pharmaceuticals Innovation Hub in Melbourne. The Hub…
BioMelbourne Network submission to the Policy Consultation Paper – Visa Simplification: Transforming Australia’s Visa System
“Australia’s visa system must remain globally competitive to attract talent to build future industries and transition to a knowledge-led economy” Health is a global market and access to global talent is critical for healthcare innovation. Companies need to…
September 2017 – Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria
Continued Discussions : Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria BioMelbourne Network convened a roundtable with Minister Wade Noonan, Minister Philip Dalidakis and 14 pharmaceutical and biotechnology companies who currently manufacture or develop products for manufacture in Victoria…
Joint Statement on Skilled Migration Visa Changes
Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six representative organisations.…
